| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Protokinetix, Inc. (PKTX) has 0 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. PKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | Smith Clarence Edward | President &CEO | Buy | 2,000,000 | $0.01 | $20,000.00 | +2.9% | |
| Jun 14, 2024 | Smith Clarence Edward | President &CEO | Buy | 6,500,000 | $0.01 | $65,000.00 | +5.1% | |
| Mar 29, 2024 | Smith Clarence Edward | President &CEO | Buy | 3,166,667 | $0.01 | $35,000.01 | +2.7% | |
| Dec 26, 2023 | Smith Clarence Edward | President &CEO | Buy | 7,333,334 | $0.02 | $110,000.01 | +14.3% | |
| Oct 26, 2023 | Guzzetta Michael Richard | CFO | Buy | 20,000 | $0.02 | $330.00 | +2.8% | |
| Aug 29, 2023 | Smith Clarence Edward | President &CEO | Buy | 1,500,000 | $0.02 | $30,000.00 | +3.0% | |
| Jun 15, 2023 | Smith Clarence Edward | President &CEO | Buy | 2,000,000 | $0.02 | $40,000.00 | +4.2% | |
| May 22, 2023 | Smith Clarence Edward | President &CEO | Buy | 3,750,000 | $0.02 | $75,000.00 | +8.5% | |
| Jan 23, 2023 | Smith Clarence Edward | President &CEO | Buy | 2,000,000 | $0.02 | $40,000.00 | +4.8% | |
| Dec 30, 2022 | Smith Clarence Edward | President &CEO | Buy | 2,187,489 | $0.02 | $46,867.78 | +2.3% |